Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × trifluridine tipiracil drug combination × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Stomach Neoplasms 2 Rectal Neoplasms 2 Colonic Neoplasms 2 Advanced Solid Tumors 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Microsatellite-stable Colorectal Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gallbladder Neoplasms 1 Digestive System Diseases 1 Colorectal Cancer Metastatic 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Advanced/Metastatic Solid Tumors 1 Advanced Gastric Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 11 pembrolizumab 8 Paclitaxel 7 Drug Therapy 6 Irinotecan 4 Fluorouracil 4 Carboplatin 4 toripalimab 3 Radiotherapy 3 tislelizumab 2 nimotuzumab 2 Oxaliplatin 2 Nivolumab 2 Levoleucovorin 2 Leucovorin 2 Docetaxel 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 regorafenib 1 osimertinib 1 nedaplatin 1 lenvatinib 1 futibatinib 1 durvalumab 1 camrelizumab 1 atezolizumab 1 aflibercept 1 Tiragolumab 1 Surgical Procedures, Operative 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡